(Nicotine replacement therapies: patient safety and persistence) |
|||
| Line 65: | Line 65: | ||
**lack of a perceived advantage of alternative products over smoking; | **lack of a perceived advantage of alternative products over smoking; | ||
**and a perceived lack of information about relative harms of NCNP compared to smoking. | **and a perceived lack of information about relative harms of NCNP compared to smoking. | ||
===2011: [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3417926/ Nicotine replacement therapies: patient safety and persistence]=== | |||
*The exact role and effects of treatment may not be the only aspect of medication use that smokers are misinformed about: a number of studies have reported that a large proportions of smokers have concerns about the safety and efficacy of NRT products, believing either that these products do not promote cessation, that they are dangerous/ harmful to use, or that the mechanism of action of nicotine replacement products is to make a user sick if they lapse during treatment. Important for the purposes of this discussion, smokers who hold these misperceptions are less likely to have used NRT in the past, and less likely to say that they intend to use it as part of future quit attempts, suggesting that beliefs about NRTs’ safety and efficacy may impact on treatment use. | |||
==Health Care== | ==Health Care== | ||
edits